News about Manufacturing

Roche's COVID-19 antibody test receives FDA Emergency Use Authorization and is available in markets

Roche's COVID-19 antibody test receives FDA Emergency Use Authorization and is available in markets

Roche has already started shipping the new antibody test to leading laboratories globally and will ramp up production capacity to high double-digit millions per month to serve healthcare systems in countries accepting the CE mark2 as well as the U.S.

Manufacturing | 04/05/2020 | By Darshana 378

Sanofi & GSK ink collaboration to develop unprecedented vaccine for COVID-19

Sanofi & GSK ink collaboration to develop unprecedented vaccine for COVID-19

Sanofi and GSK announced that they have signed a letter of intent to develop an adjuvanted vaccine for COVID-19, using innovative technology from both companies, to help address the ongoing pandemic

Manufacturing | 16/04/2020 | By Darshana 316

ICMR approves Molbio Diagnostics' testing kit for COVID-19

ICMR approves Molbio Diagnostics' testing kit for COVID-19

Molbio Diagnostics supported by India Health Fund, through the Centre for Health Research and Innovations (CHRI), has recently obtained approval from Indian Council of Medical Research (ICMR) for its testing kit -- the Truenat Beta CoV test -- to be used by patients to test for COVID-19

Manufacturing | 07/04/2020 | By Darshana 336

Lincoln Pharma continues to invest in upgrading manufacturing capacity

Lincoln Pharma continues to invest in upgrading manufacturing capacity

Lincoln Pharmaceuticals Ltd continues to invest in upgrading manufacturing capacity, new product development and expand global footprints

Manufacturing | 06/04/2020 | By Darshana 294

Lupin's Aurangabad Facility Receives EIR from U.S. FDA

Lupin's Aurangabad Facility Receives EIR from U.S. FDA

Pharma major Lupin Limited (Lupin) today announced the receipt of the Establishment Inspection Report (EIR) from the U.S. FDA for its Aurangabad, India facility. The inspection for the facility was carried out by the U.S. FDA between February 10, 2020 and February 14, 2020 and concluded with no observations

Manufacturing | 03/04/2020 | By Darshana 1057

COVID-19 Testing Kits: Mylab Signs Deal With Serum

COVID-19 Testing Kits: Mylab Signs Deal With Serum

Mylab Discovery Solutions, the first Indian company whose testing kit was approved by the Indian Council of Medical Research (ICMR), has tied up with Serum Institute of India, world's largest vaccine manufacturer by number of doses produced, to scale up the operations and escalate faster delivery of testing kits

Manufacturing | 02/04/2020 | By Darshana 425

Lupin launches Betamethasone Dipropionate Ointment USP (Augmented)

Lupin launches Betamethasone Dipropionate Ointment USP (Augmented)

Pharma major Lupin Limited (Lupin) announced the launch of Betamethasone Dipropionate Ointment USP (Augmented), 0.05%, having received an approval from the United States Food and Drug Administration (U.S. FDA) earlier. The product would be manufactured at Lupin’s Pithampur (Unit III) facility, India

Manufacturing | 21/03/2020 | By Darshana 888

BELLUS Health Announces Completion of Enrollment in Phase 2 RELIEF Trial of BLU-5937 for the Treatment of Refractory Chronic Cough

BELLUS Health Announces Completion of Enrollment in Phase 2 RELIEF Trial of BLU-5937 for the Treatment of Refractory Chronic Cough

BELLUS Health Inc, a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of chronic cough and other hypersensitization-related disorders, today announced that it has completed patient enrollment for the RELIEF trial, its dose-escalation, placebo-controlled Phase 2 trial of BLU-5937 in patients

Manufacturing | 21/03/2020 | By Darshana 496

Medivir and Tango Therapeutics sign license agreement for preclinical asset

Medivir and Tango Therapeutics sign license agreement for preclinical asset

Medivir today announced that it has entered into a license agreement with US biotech company Tango Therapeutics for one of Medivir’s preclinical research programs

Manufacturing | 17/03/2020 | By Darshana 247

Lupin launches Ethacrynic Acid Tablets USP

Lupin launches Ethacrynic Acid Tablets USP

Pharma major Lupin Limited (Lupin) announced the launch of Ethacrynic Acid Tablets USP, 25 mg, having received approval from the United States Food and Drug Administration (U.S. FDA) earlier. The product would be manufactured at Lupin's Nagpur OSD facility, India

Manufacturing | 14/03/2020 | By Darshana 746

 
 

 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members